The first family group of α1-AT-P in the world with repeated hematomas: 10-year follow-up

Abstract This case report describes the first 10-year follow-up report worldwide of a patient with the genetic variation alpha-1-antitrypsin-Pittsburgh mutation (α1-AT-P). The mutation was confirmed in a 16 year-old Chinese girl after she presented with repeated hematomas, and the mutation with bleeding tendency was also verified in her father. α1-AT-P is a spontaneously occurring autosomal dominant point mutation of α1-antitrypsin, in which methionine-358 is substituted by an arginine derivative. α1-AT-P cases are extremely rare, with only eight reported worldwide. Consequently, there is insufficient experience in the diagnosis and treatment of α1-AT-P. We followed up and reviewed the last 10 years of treatment of a young patient who suffered from repeated life-threatening hematomas, underwent emergency surgery five times, and had her ovaries removed in her twenties to avoid ovulation hemorrhage. The purpose of this article is to raise the awareness of α1-AT-P mutation and to improve its prognosis, especially in female patients.

[1]  C. Yin,et al.  Case report of the first successful cryopreserved ovarian tissue retransplantation in China , 2018, Climacteric : the journal of the International Menopause Society.

[2]  M. von Wolff,et al.  Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques , 2017, Archives of Gynecology and Obstetrics.

[3]  J. Donnez,et al.  Fertility Preservation in Women , 2017, The New England journal of medicine.

[4]  C. Frère,et al.  α1‐antitrypsin Pittsburgh and plasmin‐mediated proteolysis , 2016, Journal of thrombosis and haemostasis : JTH.

[5]  Longfei Wang,et al.  [A case of recurrent bleeding disease caused by α1 antitrypsin gene Pittsburgh mutation]. , 2015, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[6]  C. Stern,et al.  First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. , 2013, Human reproduction.

[7]  E. Tuddenham,et al.  α1-antitrypsin Pittsburgh in a family with bleeding tendency , 2009, Haematologica.

[8]  J. Emmerich α1-antitrypsin and the maintenance of hemostatic balance , 2009, Haematologica.

[9]  D. Vidaud,et al.  Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency. , 1992, The Journal of clinical investigation.

[10]  R. Bischoff,et al.  Inhibition of activated protein C by recombinant alpha 1-antitrypsin variants with substitution of arginine or leucine for methionine358. , 1990, The Journal of biological chemistry.

[11]  J H Lewis,et al.  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. , 1983, The New England journal of medicine.

[12]  J. Lewis,et al.  Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease. , 1978, Blood.